← Back to headlines
US FDA Approves Eli Lilly's Mounjaro for Cardiovascular Risk Reduction
The US Food and Drug Administration has approved Eli Lilly's diabetes drug Mounjaro to reduce cardiovascular risk, expanding its approved therapeutic uses beyond blood sugar management.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Meta Agrees to $18 Billion Settlement Over Teen Safety Lawsuit
35m ago
Waller’s Hawkish Inflation Remarks Spark Rate Hike Bets and Market Volatility
1h ago
OpenAI Terminates Partnership With SpaceX-Acquired Coding Tool Cursor
2h ago
NASA to launch $4.3bn Roman space telescope to study dark matter and exoplanets
2h ago